Evogene
EVGN
17 hedge funds and large institutions have $95.7M invested in Evogene in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.96% more ownership
Funds ownership: 0% → 1.96% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$41.2M |
| 2 |
Goldman Sachs
New York
|
+$19.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$9.62M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.34M |
| 5 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$4.43M |
Top Sellers
EVGN Hedge Fund Activity: Q4 2013 in Review
17 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q4 2013, worth a combined $95.7M.
Buyers outnumbered sellers: 17 funds opened new EVGN positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $41.2M.
- 17 institutional investors held Evogene (EVGN) as of Q4 2013, up from 0 in Q3 2013.
- Funds reported $95.7M of Evogene stock for Q4 2013.
- 17 funds opened new Evogene positions in Q4 2013 and 0 closed out, a net change of +17 holders.
- The largest Evogene buyer in Q4 2013 was Waddell & Reed Financial, an estimated $41.2M added.
Based on aggregated 13F filings for Q4 2013.